We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

44 hedge funds and large institutions have $168M invested in LianBio American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

0% more funds holding

Funds holding: 44 → 44 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

10% less capital invested

Capital invested by funds: $187M → $168M (-$19.1M)

Holders
44
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
18
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.39M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.66M
3
Barclays
Barclays
United Kingdom
+$642K
4
Citigroup
Citigroup
New York
+$619K
5
Renaissance Technologies
Renaissance Technologies
New York
+$608K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$9.98M
2
FCM
Farallon Capital Management
California
-$1.08M
3
ACM
Altium Capital Management
New York
-$681K
4
LGM
Logos Global Management
California
-$207K
5
CSS
Cubist Systematic Strategies
Connecticut
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$115M +$2.39M +998,240 +2%
VA
2
VR Adviser
New York
$10.8M – – –
Viking Global Investors
3
Viking Global Investors
Connecticut
$7.09M – – –
TCM
4
Tybourne Capital Management
Hong Kong
$6.61M -$25.4K -10,600 -0.3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$5.62M +$1.66M +695,979 +33%
VVA
6
Vida Ventures Advisors
Massachusetts
$4.56M – – –
Wellington Management Group
7
Wellington Management Group
Massachusetts
$2.05M – – –
BlackRock
8
BlackRock
New York
$2.05M -$21.5K -8,976 -0.9%
SG
9
SCHF (GPE)
Wyoming
$1.88M – – –
Citadel Advisors
10
Citadel Advisors
Florida
$1.67M +$7.17K +2,996 +0.4%
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
$1.42M – – –
Citigroup
12
Citigroup
New York
$1.41M +$619K +258,817 +58%
AAA
13
Affinity Asset Advisors
New York
$1.09M +$239K +100,000 +22%
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$858K +$239K +100,000 +30%
Renaissance Technologies
15
Renaissance Technologies
New York
$630K +$608K +254,100 +417%
LGM
16
Logos Global Management
California
$616K -$207K -86,578 -22%
Barclays
17
Barclays
United Kingdom
$537K +$642K +268,400 New
Millennium Management
18
Millennium Management
New York
$419K +$232K +97,189 +86%
CC
19
Casdin Capital
New York
$411K – – –
Marshall Wace
20
Marshall Wace
United Kingdom
$410K -$40.4K -16,894 -8%
TD Asset Management
21
TD Asset Management
Ontario, Canada
$359K +$56.4K +23,600 +15%
Victory Capital Management
22
Victory Capital Management
Texas
$347K – – –
2L
23
22NW LP
Washington
$282K – – –
GCP
24
GSA Capital Partners
United Kingdom
$252K +$70.3K +29,388 +30%
MA
25
MYDA Advisors
New York
$240K – – –
1
2

LIAN Hedge Fund Activity: Q3 2022 in Review

44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q3 2022, worth a combined $168M — down 10% from $187M a quarter earlier.

Fund positioning in LIAN was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 18 added to existing stakes and 6 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $2.39M. The largest seller was RA Capital Management, exiting entirely with an estimated $9.98M sold.

  • 44 institutional investors held LianBio American Depositary Shares (LIAN) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $168M of LianBio American Depositary Shares stock for Q3 2022, down 10% quarter-over-quarter.
  • 6 funds opened new LianBio American Depositary Shares positions in Q3 2022 and 6 closed out, a net change of 0 holders.
  • The largest LianBio American Depositary Shares buyer in Q3 2022 was Perceptive Advisors, an estimated $2.39M added.
  • The largest LianBio American Depositary Shares seller in Q3 2022 was RA Capital Management, an estimated $9.98M sold.

Based on aggregated 13F filings for Q3 2022.